A clinical trial led by top neurosurgeons concludes successfully as the first completely paralyzed patient regains full lower-body mobility via a neural interface, marking a watershed moment in neurotechnology.
In what researchers are calling the most significant advancement in spinal cord injury treatment in decades, the first completely paralyzed patient has regained full walking ability using a Neuralink brain-spine interface. The achievement, published in Nature Biotechnology, demonstrates that direct neural communication can bypass damaged spinal tissue to restore complex motor function.
Michael Rodriguez, a 34-year-old former construction worker who was paralyzed from the waist down in a 2022 workplace accident, took his first unassisted steps at the Barrow Neurological Institute in Phoenix, Arizona, five months after receiving the implant system.
"I never thought I'd feel my legs again, let alone walk," Rodriguez said at a press conference. "When I took those first steps, I couldn't stop crying. It was like being reborn."
The system consists of two components: a 1,024-electrode Neuralink chip implanted in the motor cortex of the brain, and a smaller spinal stimulator placed below the level of injury. When Rodriguez intends to move his legs, the brain chip detects the neural signals and wirelessly transmits them to the spinal device, which delivers precisely patterned electrical stimulation to activate the appropriate motor neurons.
Unlike previous brain-machine interfaces that allowed paralyzed patients to control robotic limbs or computer cursors, this system restores natural movement using the patient's own muscles. Machine learning algorithms trained over three months learned to interpret Rodriguez's movement intentions and translate them into smooth, coordinated walking patterns.
"The key breakthrough was achieving bidirectional communication," explained Dr. Jaimie Henderson, neurosurgeon at Stanford University and co-investigator on the trial. "The patient doesn't just send commands—he receives sensory feedback. When his foot touches the ground, signals travel back to his brain. This creates a closed loop that enables natural, adaptive movement."
Rodriguez can now walk at speeds up to 2.5 miles per hour, climb stairs, and even jog short distances. Sensation has partially returned to his legs, though full sensory restoration remains a goal for future development.
The trial, which includes 10 patients with complete spinal cord injuries, has shown varying degrees of success. Seven patients have regained walking ability, while three have achieved improved but not independent mobility. Researchers are working to understand why some patients respond better than others.
Regulatory approval may come faster than expected. The FDA has granted breakthrough device designation to the system, and Neuralink is in discussions about an accelerated approval pathway based on the extraordinary clinical results.
Ethicists have raised questions about equity of access, given that the current system costs over $300,000. Neuralink has committed to establishing a foundation to support patients who cannot afford the procedure, and is working on manufacturing improvements that could reduce costs significantly.
"This is day one of a new chapter in human capability," said Elon Musk, Neuralink's founder. "We're not just treating paralysis—we're beginning to merge human intention with technological execution in ways that will transform what it means to have a disability."